Results 131 to 140 of about 1,335,871 (234)

Does Robotic Segmentectomy Improve Long-Term Outcomes in Non-Small Cell Lung Cancer? [PDF]

Eur J Cardiothorac Surg
Fabbri G, Berjaoui N, Lampridis S, Maraschi A, Harrison-Phipps K, Routledge T, Dell'Amore A, Patel A, Bille A.   +8 more
europepmc   +1 more source

Peritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer: review of the literature. [PDF]

Cancer Metastasis Rev
Meriggi F, Cherri S, Gavezzoli D, Sabatini T, Bna C, Zaniboni A.   +5 more
europepmc   +1 more source

Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer. [PDF]

Cancer Immunol Immunother
Yoshichika R, Mukohara F, Yamada K, Nagasaki J, Watanabe H, Ueda Y, Suzawa K, Shien K, Toyooka S, Ishino T, Togashi Y.   +10 more
europepmc   +1 more source

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

Mayo Clinic proceedings, 2008
J. Molina, Ping Yang, S. Cassivi, S. Schild, A. Adjei   +4 more
semanticscholar   +1 more source

Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancer. [PDF]

Front Oncol
Patel SP, Gainor J, Kao S, Lee SH, Mok T, Shah R, Zhou C, Peters S.   +7 more
europepmc   +1 more source

Molecular typing of stage IB non-small-cell lung cancer for precision medicine. [PDF]

Front Oncol
Li X, Wan Z, Wen M, Zhu J, Wei K, Ji X, Zhang J, Li G, Lei J, Feng Y, Xiong Y, Zhou Y, Xin S.   +12 more
europepmc   +1 more source

GPR54 regulates non-small cell lung cancer development via dopa decarboxylase. [PDF]

Signal Transduct Target Ther
Hwang HH, Lee SY, Lee C, Lee JY, Ko SG, Cho SG.   +5 more
europepmc   +1 more source

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Journal of Clinical Oncology, 2008
G. Scagliotti, P. Parikh, J. von Pawel, B. Biesma, J. Vansteenkiste, C. Manegold, P. Serwatowski, U. Gatzemeier, R. Digumarti, M. Zukin, J. S. Lee, A. Mellemgaard, Keunchil Park, S. Patil, J. Rolski, T. Goksel, F. de Marinis, L. Simms, K. Sugarman, D. Gandara   +19 more
semanticscholar   +1 more source

Aumolertinib combined with targeting <i>ETV4</i> in the treatment of non-small cell lung cancer. [PDF]

J Thorac Dis
Lu Y, Tang D, Zhang H, Yang Z, Wang J, Gao W.   +5 more
europepmc   +1 more source

Durvalumab after Chemoradiotherapy in Stage III Non–Small‐Cell Lung Cancer

New England Journal of Medicine, 2017
S. Antonia, A. Villegas, D. Daniel, D. Vicente, S. Murakami, R. Hui, T. Yokoi, A. Chiappori, K. Lee, M. de Wit, B. Cho, M. Bourhaba, X. Quantin, T. Tokito, T. Mekhail, D. Planchard, Young‐Chul Kim, C. Karapetis, S. Hiret, G. Ostoros, K. Kubota, J. Gray, L. Paz-Ares, J. de Castro Carpeño, C. Wadsworth, G. Melillo, Haiyi Jiang, Yi-fan Huang, P. Dennis, M. Özgüroğlu   +29 more
semanticscholar   +1 more source